Make your money go further for just 25p per day

PREMIUM
AIM IHT

Stunning results | Careful with the share class | Horrendous results

20/06/2024 · Alliance Pharma (APH)  · Intercede Group (IGP)  · Tatton Asset Management (TAM)  · Victoria (VCP)  · Young & Co. (YNGA) 

AIM AIM Inheritance Tax potential UK

Pub scene in the style of John Constable

News covered here includes our assessment of some stunning results from two AIM companies, both of which still have plenty of ambition. Elsewhere, potential investors in a popular pub group need to be careful which class of share they buy, while the long-awaited results from healthcare group lift the shares. Unfortunately, there was more questionable reporting from a flooring manufacturer which continues to be weighed down by a huge amount of debt.


Episode 22 of the Investor’s Champion Podcast

In this episode of the Investors Champion podcast, hosts Chris and Lee delve into several key topics shaping the UK investment landscape.

They start by celebrating the recent IPO of Raspberry Pi on the London Stock Exchange, highlighting the firm's market performance and its far-reaching applications. The conversation then transitions to Elon Musk's controversial pay deal and its potential implications for Tesla…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alliance Pharma

AIM takeovers | Automotive excellence and struggles

01/10/2024 · Company Insights

One of AIM’s largest companies seems inclined to accept a private equity funded offer, with an…


Stunning results | Careful with the share class | Horrendous results

20/06/2024 · Company Insights

News covered here includes our assessment of some stunning results from two AIM companies, both of…


More on Intercede Group

Big upgrade | Data winner | Bonkers Bargain impresses

03/09/2024 · Company Insights

News covered here incudes our assessment of impressive results from one of our Bonkers Bargain opportunities.…


Episode 24 of the Investor’s Champion Podcast

30/06/2024 · Podcasts

In this episode of the Investor's Champion Podcast, hosts Chris and Lee focus on the world…


More on Tatton Asset Management

Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…


More on Victoria

Improving returns | Questionable business models

20/11/2024 · Company Insights

A software provider whose results we assess here continues to recover from the consequences of a…


Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…


More on Young & Co.

Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP